Menu
GWAS Study

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.

Karnes JH, Rollin J, Giles JB et al.

35377938 PubMed ID
GWAS Study Type
2780 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KJ
Karnes JH
RJ
Rollin J
GJ
Giles JB
MK
Martinez KL
SH
Steiner HE
SC
Shaffer CM
MY
Momozawa Y
IC
Inai C
BA
Bombin A
SM
Shi M
MJ
Mosley JD
SI
Stanaway I
SK
Selleng K
TT
Thiele T
MT
Mushiroda T
PC
Pouplard C
HN
Heddle NM
KM
Kubo M
PE
Phillips EJ
WT
Warkentin TE
GY
Gruel Y
GA
Greinacher A
RD
Roden DM
Chapter II

Abstract

Summary of the research findings

Heparin-induced thrombocytopenia (HIT) is an unpredictable, potentially catastrophic adverse effect resulting from an immune response to platelet factor 4 (PF4)/heparin complexes. We performed a genome-wide association study (GWAS) with positive functional assay as the outcome in a large discovery cohort of patients divided into 3 groups: (1) functional assay-positive cases (n = 1269), (2) antibody-positive (functional assay-negative) controls (n = 1131), and (3) antibody-negative controls (n = 1766). Significant associations (α = 5 × 10-8) were investigated in a replication cohort (α = 0.05) of functional assay-confirmed HIT cases (n = 177), antibody-positive (function assay-negative) controls (n = 258), and antibody-negative controls (n = 351). We observed a strong association for positive functional assay with increasing PF4/heparin immunoglobulin-G (IgG) level (odds ratio [OR], 16.53; 95% confidence interval [CI], 13.83-19.74; P = 1.51 × 10-209) and female sex (OR, 1.15; 95% CI, 1.01-1.32; P = .034). The rs8176719 C insertion variant in ABO was significantly associated with positive functional assay status in the discovery cohort (frequency = 0.41; OR, 0.751; 95% CI, 0.682-0.828; P = 7.80 × 10-9) and in the replication cohort (OR, 0.467; 95% CI, 0.228-0.954; P = .0367). The rs8176719 C insertion, which encodes all non-O blood group alleles, had a protective effect, indicating that the rs8176719 C deletion and the O blood group were risk factors for HIT (O blood group OR, 1.42; 95% CI, 1.26-1.61; P = 3.09 × 10-8). Meta-analyses indicated that the ABO association was independent of PF4/heparin IgG levels and was stronger when functional assay-positive cases were compared with antibody-positive (functional assay-negative) controls than with antibody-negative controls. Sequencing and fine-mapping of ABO demonstrated that rs8176719 was the causal single nucleotide polymorphism (SNP). Our results clarify the biology underlying HIT pathogenesis with ramifications for prediction and may have important implications for related conditions, such as vaccine-induced thrombotic thrombocytopenia.

1,422 European ancestry cases, 1,358 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2780
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.